GlycoMimetics Inc is a clinical stage biotechnology company. The Company is engaged in discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in which carbohydrate biology plays a key role.
| Website: | www.glycomimetics.com |
| Main Phone: | +1 240 243-1201 |
| Address: | 9708 Medical Center Drive |
| Address 2: | Suite 250 |
| State: | MD |
| City / Town: | Rockville |
| Country: | USA |
| Postal Code: | 20850 |
| Exchange: | NSD |
| Employees: | 38 |
| NAICS: | Pharmaceutical P |
| Last Price 11.50 | Change $ -0.33 | Change % -2.79 | Tick N/A |
| Bid N/A | Bid Size 0.00 | Ask 11.93 | Ask Size 100.00 |
| Open 11.78 | High 11.96 | Low 11.46 | Prev Close 11.83 |
| Last Trade | Volume 200,440 | 52 Wk Hi 16.94 | 52 Wk Low 3.82 |
| Market Cap 375.9 mi | Ex-Div Date N/A | Div Rate N/A | Yield N/A |
| Shares 32,690,350.00 | EPS (TTM) -1.45 | PE Ratio N/A | Exchange NSD |
|
|
|
|
| Last 3 Mo | Last 12 Mo | |
|---|---|---|
| Number of Insider Trades | 5 | 16 |
| Number of Buys | 1 | 6 |
| Number of Sells | 4 | 10 |
| Net Activity | -23395 | -2665 |
| Last 10 Buys | Shares |
|---|---|
| Mark A. Goldberg | 1,000 |
| Michael A. Henos | 1,000 |
| Michael A. Henos | 1,000 |
| Last 10 Sell | Shares |
|---|---|
| Helen M. Thackray | 1,000 |
| Helen M. Thackray | 1,000 |
| Helen M. Thackray | 1,000 |
| Helen M. Thackray | 1,000 |
| Peter J. Barris | 1,000 |
| Sandell D Scott | 1,000 |
| M. James Barrett | 1,000 |
| Michael A. Henos | 1,000 |
| Michael A. Henos | 1,000 |
| Michael A. Henos | 1,000 |
| Current | 1 Week Ago | 2 Weeks Ago | 3 Weeks Ago | |
|---|---|---|---|---|
| High Target Price Estimate | 16 | 16 | 16 | 16 |
| Low Target Price Estimate | 11 | 11 | 11 | 11 |
| Mean Target Price Estimate | 14 | 14 | 13.33 | 14 |
| Standard Deviation | 2.65 | 2.65 | 2.52 | 2.65 |
| Date of Most Recent Estimate | 08/05/16 | 08/05/16 | 07/26/16 | 08/05/16 |
| Form Type | Form Description | Pages | Date |
|---|---|---|---|
| 8-K | Report of unscheduled material events or corporate changes. | 8 | 2016-08-04 |
| 10-Q | Quarterly report with a continuing view of a company's financial position | 33 | 2016-08-04 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2016-07-21 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2016-07-06 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2016-07-01 |
| SC 13G | Statement of beneficial ownership of common stock by certain persons | 15 | 2016-06-27 |
| 8-K | Report of unscheduled material events or corporate changes. | 57 | 2016-06-17 |
| 424B5 | Prospectus filed under Rule 424(b)(5) | 64 | 2016-06-17 |
| 424B5 | Prospectus filed under Rule 424(b)(5) | 64 | 2016-06-16 |
| 8-K | Report of unscheduled material events or corporate changes. | 8 | 2016-06-10 |
| Current | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
|---|---|---|---|---|
| Strong Buy | 4 | 2 | 2 | 2 |
| Moderate Buy | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 |
| Moderate Sell | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 |
| Mean Rec. | 1 | 1 | 1 | 1 |
© 2017 Equities
* All dates and time are being displayed in Eastern Standard Time (EST).
